Dachaigh › Luchd-obrach › Lyterian Therapeutics
Lyterian Therapeutics: Tuarastalan H-1B agus taic bhìosa
Chuir Lyterian Therapeutics 8 iarrtasan cumha-obrach a-steach airson bhìosaichean H-1B agus bhìosaichean co-cheangailte ann am bliadhnaichean ionmhais 2023–2026; le teisteanas: 8. Tuarastal meadhanach a chaidh a thabhann: $145,180.
A bheil Lyterian Therapeutics a’ toirt taic do bhìosaichean H-1B?
Chuir Lyterian Therapeutics 8 iarrtasan cumha-obrach a-steach ann am bliadhnaichean ionmhais 2023–2026, an tè as ùire air a chur a-steach air 23 Faoi 2025. Is e LCA a’ chiad cheum ann an iarrtas H-1B, mar sin tha an neach-fastaidh air taic a thoirt do luchd-obrach H-1B no air ullachadh airson sin a dhèanamh; cha gharantaich e taic airson dreuchd shònraichte sam bith. Thoir sùil air liostaichean obrach an neach-fastaidh fhèin.
Tuarastalan a rèir tiotal obrach
| Tiotal dreuchd | LCAs | Tuarastal meadhanach |
|---|---|---|
| Executive Director, Early Lead Chemistry | 2 | $275,400 |
| Scientist I | 2 | $131,650 |
| Senior Scientist, Medicinal Chemistry | 1 | $147,659 |
| Senior Research Associate | 1 | $100,000 |
| Scientist II | 1 | $142,700 |
| Senior Scientist | 1 | $166,000 |
Iarrtasan a rèir bliadhna ionmhais
| Bliadhna mhaoine | LCAs | Tuarastal meadhanach |
|---|---|---|
| FY2023 | 3 | $147,659 |
| FY2024 | 2 | $116,650 |
| FY2025 | 3 | $166,000 |
Ìrean tuarastail làithreach
Suidhichidh Roinn an Obrach ceithir ìrean tuarastail làithreach airson gach dreuchd agus sgìre, bho Ìre I (inntrigeadh) gu Ìre IV (gu tur comasach). Taghaidh an neach-fastaidh an ìre a fhreagras ri riatanasan na h-obrach.
Far a bheil na h-obraichean
Dreuchdan
- Biochemists and Biophysicists3
- Chemists2
- Medical Scientists, Except Epidemiologists2
- Bioengineers and Biomedical Engineers1
Iarrtasan as ùire
| Tiotal dreuchd | Tuarastal bunasach | Àite | Air a chur a-steach | Ceann-latha tòiseachaidh | Inbhe |
|---|---|---|---|---|---|
| Senior Scientist | $166,000 E-3 · Ìre II | S. San Francisco, CA | 23 Faoi 2025 | 23 Faoi 2025 | Dearbhaichte |
| Executive Director, Early Lead Chemistry | $280,800 E-3 · Ìre IV | South San Francisco, CA | 11 Dùbh 2024 | 17 Dùbh 2024 | Dearbhaichte |
| Scientist II | $142,700 E-3 · Ìre II | South San Francisco, CA | 12 Samh 2024 | 1 Faoi 2025 | Dearbhaichte |
| Scientist I | $133,300 Ìre II | South San Francisco, CA | 13 Cèit 2024 | 1 Dàmh 2024 | Dearbhaichte |
| Senior Research Associate | $100,000 Ìre I | South San Francisco, CA | 10 Cèit 2024 | 1 Dàmh 2024 | Dearbhaichte |
| Scientist I | $130,000 E-3 · Ìre II | South San Francisco, CA | 21 Ògmh 2023 | 10 Iuch 2023 | Dearbhaichte |
| Senior Scientist, Medicinal Chemistry | $147,659–$160,000 Ìre IV | South San Francisco, CA | 17 Cèit 2023 | 20 Cèit 2023 | Dearbhaichte |
| Executive Director, Early Lead Chemistry | $270,000 E-3 · Ìre IV | San Francisco, CA | 31 Faoi 2023 | 14 Gearr 2023 | Dearbhaichte |
Is e na tuarastalan an ìre as ìsle den tuarastal a chaidh a thabhann air gach iarrtas, air an tionndadh gu suim bhliadhnail; cleachdaidh na staitistigean iarrtasan làn-aimsire le teisteanas a-mhàin. Chan eil LCA na aontachadh bhìosa agus faodaidh aon LCA còmhdach a dhèanamh air iomadh dreuchd. Stòr: Roinn an Obrach na SA, Dàta Foillseachaidh OFLC LCA, bliadhnaichean ionmhais 2023–2026 (co-dhùnadh as ùire 30 Ògmh 2026).